Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins

Abstract excerpt

CRISPR/Cas9 technology is accelerating genome engineering in many cell types, but so far, gene delivery and stable gene modification have been challenging in primary NK cells. For example, transgene delivery using lentiviral or retroviral transduction resulted in a limited yield of genetically-engineered NK cells due to substantial procedure-associated NK cell apoptosis. We describe here a DNA-free method for...

Topics

Join the communities discussing this publication.

• CAR-T cell therapy research
• CRISPR and Genetic Engineering
• Immune Cell Function and Interaction